{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T16:02:21Z","timestamp":1791129741528,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2004,2,24]],"date-time":"2004-02-24T00:00:00Z","timestamp":1077580800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1038\/sj.bjc.6601656","type":"journal-article","created":{"date-parts":[[2004,3,16]],"date-time":"2004-03-16T18:11:53Z","timestamp":1079460713000},"page":"1244-1251","source":"Crossref","is-referenced-by-count":45,"title":["BRCA1 and BRCA2 germline mutation spectrum and frequencies in Belgian breast\/ovarian cancer families"],"prefix":"10.1038","volume":"90","author":[{"given":"K","family":"Claes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Poppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Coene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A De","family":"Paepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Messiaen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,2,24]]},"reference":[{"key":"BF6601656_CR1","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1038\/sj.bjc.6600628","volume":"87","author":"A Baeyens","year":"2002","unstructured":"Baeyens A, Thierens H, Claes K, Poppe B, Messiaen L, De Ridder L, Vral A (2002) Chromosomal radiosensitivity in breast cancer patients with a known or putative genetic predisposition. Br J Cancer 87: 1379\u20131385","journal-title":"Br J Cancer"},{"key":"BF6601656_CR2","doi-asserted-by":"publisher","first-page":"R2","DOI":"10.1186\/bcr419","volume":"4","author":"VM Basham","year":"2002","unstructured":"Basham VM, Lipscombe JM, Ward JM, Gayther SA, Ponder BA, Easton DF, Pharoah PD (2002) BRCA1 and BRCA2 mutations in a population-based study of male breast cancer. Breast Cancer Res 4: R2","journal-title":"Breast Cancer Res"},{"key":"BF6601656_CR3","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1136\/jmg.38.6.361","volume":"38","author":"JT Bergthorsson","year":"2001","unstructured":"Bergthorsson JT, Ejlertsen B, Olsen JH, Borg A, Nielsen KV, Barkardottir RB, Klausen S, Mouridsen HT, Winther K, Fenger K, Niebuhr A, Harboe TL, Niebuhr E (2001) BRCA1 and BRCA2 mutation status and cancer family history of Danish women affected with multifocal or bilateral breast cancer at a young age. J Med Genet 38: 361\u2013368","journal-title":"J Med Genet"},{"key":"BF6601656_CR4","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1001\/jama.283.17.2260","volume":"283","author":"J Boyd","year":"2000","unstructured":"Boyd J, Sonoda Y, Federici MG, Bogomolniy F, Rhei E, Maresco DL, Saigo PE, Almadrones LA, Barakat RR, Brown CL, Chi DS, Curtin JP, Poynor EA, Hoskins WJ (2000) Clinicopathologic features of BRCA-linked and sporadic ovarian cancer. JAMA 283: 2260\u20132265","journal-title":"JAMA"},{"key":"BF6601656_CR5","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/(SICI)1098-1004(1999)13:3<256::AID-HUMU12>3.0.CO;2-M","volume":"13","author":"K Claes","year":"1999","unstructured":"Claes K, Machackova E, De Vos M, Mortier G, De Paepe A, Messiaen L (1999a) Mutation analysis of the BRCA1 and BRCA2 genes results in the identification of novel and recurrent mutations in 6\/16 Flemish families with breast and\/or ovarian cancer but not in 12 sporadic patients with early-onset disease. Mutations in brief no. 224. Online. Hum Mutat 13: 256","journal-title":"Hum Mutat"},{"key":"BF6601656_CR6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1155\/1999\/241046","volume":"15","author":"K Claes","year":"1999","unstructured":"Claes K, Machackova E, De Vos M, Poppe B, De Paepe A, Messiaen L (1999b) Mutation analysis of the BRCA1 and BRCA2 genes in the Belgian patient population and identification of a Belgian founder mutation BRCA1 IVS5+3A&gt;G. Dis Markers 15: 69\u201373","journal-title":"Dis Markers"},{"key":"BF6601656_CR7","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/gcc.10221","volume":"37","author":"K Claes","year":"2003","unstructured":"Claes K, Poppe B, Machackova E, Coene I, Foretova L, De Paepe A, Messiaen L (2003) Differentiating pathogenic mutations from polymorphic alterations in the splice sites of BRCA1 and BRCA2. Genes Chromosomes Cancer 37: 314\u2013320","journal-title":"Genes Chromosomes Cancer"},{"key":"BF6601656_CR8","doi-asserted-by":"publisher","first-page":"4171","DOI":"10.1038\/sj.onc.1205520","volume":"21","author":"K Claes","year":"2002","unstructured":"Claes K, Vandesompele J, Poppe B, Dahan K, Coene I, De Paepe A, Messiaen L (2002) Pathological splice mutations outside the invariant AG\/GT splice sites of BRCA1 exon 5 increase alternative transcript levels in the 5\u2032 end of the BRCA1 gene. Oncogene 21: 4171\u20134175","journal-title":"Oncogene"},{"key":"BF6601656_CR9","unstructured":"Claes K, Poppe B, Szabo C, Thompson D, Peyrat JP, Fournier J, Coene I, Schelfhoul V, De Paepe A, Messiaen L . A common ancestor for Belgian and French patients bearing BRCA1 1VS5+3A&gt;G. Submitted"},{"key":"BF6601656_CR10","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1056\/NEJM199705153362002","volume":"336","author":"FJ Couch","year":"1997","unstructured":"Couch FJ, DeShano ML, Blackwood MA, Calzone K, Stopfer J, Campeau L, Ganguly A, Rebbeck T, Weber BL (1997) BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 336: 1409\u20131415","journal-title":"N Engl J Med"},{"key":"BF6601656_CR11","first-page":"995","volume":"59","author":"B Csokay","year":"1999","unstructured":"Csokay B, Udvarhelyi N, Sulyok Z, Besznyak I, Ramus S, Ponder B, Olah E (1999) High frequency of germ-line BRCA2 mutations among Hungarian male breast cancer patients without family history. Cancer Res 59: 995\u2013998","journal-title":"Cancer Res"},{"key":"BF6601656_CR12","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/ijc.1627","volume":"97","author":"M de la Hoya","year":"2002","unstructured":"de la Hoya M, Osorio A, Godino J, Sulleiro S, Tosar A, Perez-Segura P, Fernandez C, Rodriguez R, Diaz-Rubio E, Benitez J, Devilee P, Caldes T (2002) Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast\/ovarian cancer families: implications for genetic testing. Int J Cancer 97: 466\u2013471","journal-title":"Int J Cancer"},{"key":"BF6601656_CR13","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1155\/1999\/809125","volume":"15","author":"M De Vos","year":"1999","unstructured":"De Vos M, Poppe B, Delvaux I, Mortier G, Claes K, Messiaen L, De Paepe A (1999) Genetic counselling and testing for hereditary breast and ovarian cancer: the gent(le) approach. Dis Markers 15: 191\u2013195","journal-title":"Dis Markers"},{"key":"BF6601656_CR14","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1086\/342192","volume":"71","author":"JD Fackenthal","year":"2002","unstructured":"Fackenthal JD, Cartegni L, Krainer AR, Olopade OI (2002) BRCA2 T2722R is a deleterious allele that causes Exon skipping. Am J Hum Genet 71: 625\u2013631","journal-title":"Am J Hum Genet"},{"key":"BF6601656_CR15","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1086\/301749","volume":"62","author":"D Ford","year":"1998","unstructured":"Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck TR, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder BA, Gayther SA, Birch JM, Lindblom A, Stoppa-Lyonnet D, Bignon Y, Borg A, Hamann U, Haites N, Scott RJ, Maugard CM, Vasen H, Seitz S, Cannon-Albright LA, Schofield A, Zelada-Hedman M, Breast Cancer Linkage Consortium (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 62: 676\u2013689","journal-title":"Am J Hum Genet"},{"key":"BF6601656_CR16","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1200\/JCO.2002.20.6.1480","volume":"20","author":"TS Frank","year":"2002","unstructured":"Frank TS, Deffenbaugh AM, Reid JE, Hulick M, Ward BE, Lingenfelter B, Gumpper KL, Scholl T, Tavtigian SV, Pruss DR, Critchfield GC (2002) Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 20: 1480\u20131490","journal-title":"J Clin Oncol"},{"key":"BF6601656_CR17","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1200\/JCO.1998.16.7.2417","volume":"16","author":"TS Frank","year":"1998","unstructured":"Frank TS, Manley SA, Olopade OI, Cummings S, Garber JE, Bernhardt B, Antman K, Russo D, Wood ME, Mullineau L, Isaacs C, Peshkin B, Buys S, Venne V, Rowley PT, Loader S, Offit K, Robson M, Hampel H, Brener D, Winer EP, Clark S, Weber B, Strong LC, Rieger P, McClure M, Ward BE, Shattuck-Eidens D, Oliphant A, Skolnick MH, Thomas A (1998) Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. J Clin Oncol 16: 2417\u20132425","journal-title":"J Clin Oncol"},{"key":"BF6601656_CR18","first-page":"313","volume":"60","author":"LS Friedman","year":"1997","unstructured":"Friedman LS, Gayther SA, Kurosaki T, Gordon D, Noble B, Casey G, Ponder BA, Anton-Culver H (1997) Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. Am J Hum Genet 60: 313\u2013319","journal-title":"Am J Hum Genet"},{"key":"BF6601656_CR19","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/ng0197-103","volume":"15","author":"SA Gayther","year":"1997","unstructured":"Gayther SA, Mangion J, Russell P, Seal S, Barfoot R, Ponder BA, Stratton MR, Easton D (1997) Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene. Nat Genet 15: 103\u2013105","journal-title":"Nat Genet"},{"key":"BF6601656_CR20","first-page":"304","volume":"36","author":"G Goelen","year":"1999","unstructured":"Goelen G, Teugels E, Bonduelle M, Neyns B, De Greve J (1999) High frequency of BRCA1\/2 germline mutations in 42 Belgian families with a small number of symptomatic subjects. J Med Genet 36: 304\u2013308","journal-title":"J Med Genet"},{"key":"BF6601656_CR21","first-page":"1367","volume":"58","author":"K Haraldsson","year":"1998","unstructured":"Haraldsson K, Loman N, Zhang QX, Johannsson O, Olsson H, Borg A (1998) BRCA2 germ-line mutations are frequent in male breast cancer patients without a family history of the disease. Cancer Res 58: 1367\u20131371","journal-title":"Cancer Res"},{"key":"BF6601656_CR22","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/ng0695-208","volume":"10","author":"FB Hogervorst","year":"1995","unstructured":"Hogervorst FB, Cornelis RS, Bout M, van Vliet M, Oosterwijk JC, Olmer R, Bakker B, Klijn JG, Vasen HF, Meijers-Heijboer H, Menko FH, Cornelisse CJ, Den Dunnen JT, Devilee P, Van Ommen GJB (1995) Rapid detection of BRCA1 mutations by the protein truncation test. Nat Genet 10: 208\u2013212","journal-title":"Nat Genet"},{"key":"BF6601656_CR23","first-page":"1449","volume":"63","author":"FB Hogervorst","year":"2003","unstructured":"Hogervorst FB, Nederlof PM, Gille JJ, McElgunn CJ, Grippeling M, Pruntel R, Regnerus R, van Welsem T, van Spaendonk R, Menko FH, Kluijt I, Dommering C, Verhoef S, Schouten JP, van't Veer LJ, Pals G (2003) Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method. Cancer Res 63: 1449\u20131453","journal-title":"Cancer Res"},{"key":"BF6601656_CR24","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/1097-0215(20010101)91:1<83::AID-IJC1013>3.0.CO;2-5","volume":"91","author":"N Ikeda","year":"2001","unstructured":"Ikeda N, Miyoshi Y, Yoneda K, Shiba E, Sekihara Y, Kinoshita M, Noguchi S (2001) Frequency of BRCA1 and BRCA2 germline mutations in Japanese breast cancer families. Int J Cancer 91: 83\u201388","journal-title":"Int J Cancer"},{"key":"BF6601656_CR25","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1086\/342506","volume":"71","author":"A Liede","year":"2002","unstructured":"Liede A, Malik IA, Aziz Z, Rios Pd Pde L, Kwan E, Narod SA (2002) Contribution of BRCA1 and BRCA2 mutations to breast and ovarian cancer in Pakistan. Am J Hum Genet 71: 595\u2013606","journal-title":"Am J Hum Genet"},{"key":"BF6601656_CR26","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1126\/science.7545954","volume":"266","author":"Y Miki","year":"1994","unstructured":"Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayanath P, Ward J, Tonin P, Narod S, Bristow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barret JC, Lewis C, Neuhausen S, Cannon-albright L, Golgdgar D, Wiseman R, Kamb A, Skolnick MH (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66\u201371","journal-title":"Science"},{"key":"BF6601656_CR27","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1093\/hmg\/ddg120","volume":"12","author":"M Montagna","year":"2003","unstructured":"Montagna M, Palma MD, Menin C, Agata S, De Nicolo A, Chieco-Bianchi L, D\u2019Andrea E (2003) Genomic rearrangements account for more than one-third of the BRCA1 mutations in northern Italian breast\/ovarian cancer families. Hum Mol Genet 12: 1055\u20131061","journal-title":"Hum Mol Genet"},{"key":"BF6601656_CR28","first-page":"1041","volume":"60","author":"T Peelen","year":"1997","unstructured":"Peelen T, van Vliet M, Petrij-Bosch A, Mieremet R, Szabo C, van den Ouweland AMW, Hogervorst F, Brohet R, Ligtenberg MJL, Teugels E, van der Luijt R, van der Hout AH, Gille JJP, Pals G, Jedema I, Olmer R, van Leeuwen I, Newman B, Plandsoen M, van der Est M, Brink G, Hageman S, Arts PJW, Bakker MM, Willems HW, van der Looji E, Neyns B, Bonduelle M, Jansen R, Oosterwijk JC, Sijmons R, Smeets HJM, van Asperen CJ, Meijers-Heijboer H, Klijn JGM, de Greve J, King M-C, Menko FH, Brunner HG, Halley D, van Ommen G-JB, Vasen HFA, Cornelisse CJ, van\u2019t Veer LJ, de Knijff P, Bakker E, Devilee P (1997) A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families. Am J Hum Genet 60: 1041\u20131049","journal-title":"Am J Hum Genet"},{"key":"BF6601656_CR29","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/ng1197-341","volume":"17","author":"A Petrij-Bosch","year":"1997","unstructured":"Petrij-Bosch A, Peelen T, van Vliet M, van Eijk R, Olmer R, Drusedau M, Hogervorst FB, Hageman S, Arts PJ, Ligtenberg MJ, Meijers-Heijboer H, Klijn JG, Vasen HF, Cornelisse CJ, van\u2019t Veer LJ, Bakker E, van Ommen GJ, Devilee P (1997) BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients. Nat Genet 17: 341\u2013345","journal-title":"Nat Genet"},{"key":"BF6601656_CR30","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1086\/302211","volume":"64","author":"N Puget","year":"1999","unstructured":"Puget N, Sinilnikova OM, Stoppa-Lyonnet D, Audoynaud C, Pages S, Lynch HT, Goldgar D, Lenoir GM, Mazoyer S (1999) An Alu-mediated 6-kb duplication in the BRCA1 gene: a new founder mutation? Am J Hum Genet 64: 300\u2013302","journal-title":"Am J Hum Genet"},{"key":"BF6601656_CR31","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1086\/318787","volume":"68","author":"HA Risch","year":"2001","unstructured":"Risch HA, McLaughlin JR, Cole DE, Rosen B, Bradley L, Kwan E, Jack E, Vesprini DJ, Kuperstein G, Abrahamson JL, Fan I, Wong B, Narod SA (2001) Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet 68: 700\u2013710","journal-title":"Am J Hum Genet"},{"key":"BF6601656_CR32","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/1098-2264(200007)28:3<300::AID-GCC8>3.0.CO;2-1","volume":"28","author":"EM Rohlfs","year":"2000","unstructured":"Rohlfs EM, Puget N, Graham ML, Weber BL, Garber JE, Skrzynia C, Halperin JL, Lenoir GM, Silverman LM, Mazoyer S (2000) An Alu-mediated 7.1\u2009kb deletion of BRCA1 exons 8 and 9 in breast and ovarian cancer families that results in alternative splicing of exon 10. Genes Chromosomes Cancer 28: 300\u2013307","journal-title":"Genes Chromosomes Cancer"},{"issue":"Suppl 1","key":"BF6601656_CR33","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1097\/00008469-199802001-00002","volume":"7","author":"C Sibille-Hoang","year":"1998","unstructured":"Sibille-Hoang C, Froment O, Joos de ter Beerst A, Lepiece V, Huberlant G, Blauwaert G, Vindevoghel A, Canon JL, Gillerot Y (1998) BRCA1 and BRCA2 mutations in Belgian families with a history of breast and\/or ovarian cancer. Eur J Cancer Prev 7 (Suppl 1): S3\u2013S5","journal-title":"Eur J Cancer Prev"},{"key":"BF6601656_CR34","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1054\/bjoc.2001.2016","volume":"85","author":"D Steinmann","year":"2001","unstructured":"Steinmann D, Bremer M, Rades D, Skawran B, Siebrands C, Karstens JH, Dork T (2001) Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer. Br J Cancer 85: 850\u2013858","journal-title":"Br J Cancer"},{"key":"BF6601656_CR35","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/ng0396-333","volume":"12","author":"SV Tavtigian","year":"1996","unstructured":"Tavtigian SV, Simard J, Rommens J, Couch F, Shattuck-Eidens D, Neuhausen S, Merajver S, Thorlacius S, Offit K, Stoppa-Lyonnet D, Belanger C, Bell R, Berry S, Bogden R, Chen Q, Davis T, Dumont M, Frye C, Hattier T, Jammulapati S, Janecki T, Jiang P, Kehrer R, Leblanc JF, Mitchell JT, McArthur-Morrison J, Nguyen K, Peng Y, Samson C, Schroeder M, Snyder SC, Steele L, Stringfellow M, Stroup C, Swedlund B, Swensen J, Teng D, Thomas A, Tran T, Tranchant M, Weaver-Feldhaus J, Wong AKC, Shizuya H, Eyfjord JE, Cannon-Albright L, Labrie F, Skolnick MH, Weber B, Kamb A, Goldgar DE (1996) The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet 12: 333\u2013337","journal-title":"Nat Genet"},{"key":"BF6601656_CR36","doi-asserted-by":"crossref","unstructured":"The BRCA1 Exon 13 Duplication Screening Group (2000) The exon 13 duplication in the BRCA1 gene is a founder mutation present in geographically diverse populations. Am J Hum Genet 67: 207\u2013212","DOI":"10.1086\/302974"},{"key":"BF6601656_CR37","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1086\/318181","volume":"68","author":"D Thompson","year":"2001","unstructured":"Thompson D, Easton D (2001) Variation in cancer risks, by mutation position, in BRCA2 mutation carriers. Am J Hum Genet 68: 410\u2013419","journal-title":"Am J Hum Genet"},{"key":"BF6601656_CR38","first-page":"329","volume":"11","author":"D Thompson","year":"2002","unstructured":"Thompson D, Easton D (2002) Variation in BRCA1 cancer risks by mutation position. Cancer Epidemiol Biomarkers Prev 11: 329\u2013336","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BF6601656_CR39","first-page":"A410","volume":"65","author":"AH van der Hout","year":"1999","unstructured":"van der Hout AH, Mulder IM, Wu Y, van der Vlies P, Huisman M, Oosterwijk JC, Buys CHCM, Hofstra RMW (1999) A DGGE system for comprehensive mutation screening of the complete coding regions of BRCA1 and BRCA2 outside exons 11. Am J Hum Genet 65: A410","journal-title":"Am J Hum Genet"},{"key":"BF6601656_CR40","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/sj.onc.1206071","volume":"22","author":"JM Wong","year":"2003","unstructured":"Wong JM, Ionescu D, Ingles CJ (2003) Interaction between BRCA2 and replication protein A is compromised by a cancer-predisposing mutation in BRCA2. Oncogene 22: 28\u201333","journal-title":"Oncogene"},{"key":"BF6601656_CR41","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/378789a0","volume":"378","author":"R Wooster","year":"1995","unstructured":"Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378: 789\u2013792","journal-title":"Nature"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6601656.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6601656","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6601656.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:56:21Z","timestamp":1684414581000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6601656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2,24]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["BF6601656"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6601656","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,2,24]]}}}